Generic Weight Loss Drugs Fuel Retail Growth, but What's the Real Story?
Loblaw's recent earnings report is being hailed as a success story, thanks in part to its pharmacy unit leading same store sales growth in the second quarter.
The company's chief financial officer, Richard Dufresne, attributed this growth to the "impact of GLP 1 drugs going generic.